Xuqian Ma

Highly Potent Immunotoxins Targeting the Membrane-distal N-lobe of GPC3 for Immunotherapy of Hepatocellular Carcinoma

Hanjie Li, Yaxi Yang, Qian Wang, 2022, Journal of Cancer.

Generation of TIM3 inhibitory single-domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells

Qian Wang, Xiaoqing Yang, Qian Wang, 2021, Oncology letters.

EGFRvⅢ-targeted immunotoxin combined with temozolomide and bispecific antibody for the eradication of established glioblastoma.

Mingqian Feng, Xiaobing Jiang, Xuan Wang, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Degradation study of rutin as template from magnetic composite molecularly imprinted polymer supernatant samples by liquid chromatography-mass spectrometry.

Pierre Dramou, Xuqian Ma, Taijun Hang, 2022, Journal of Chromatography A.

Strengthening of antitumor effects in breast cancer from a novel B7-H4- and CD3-targeting bispecific antibody by an oncolytic virus

Xin Jin, C. Xie, Mingqian Feng, 2022, Annals of translational medicine.

Angptl7 promotes insulin resistance and type 2 diabetes mellitus by multiple mechanisms including SOCS3‐mediated IRS1 degradation

Xiaoqing Yang, Mingqian Feng, Yaru Zhou, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers.

Xuqian Ma, Xin Chen, Wenying Qiu, 2024, Frontiers in bioscience.